Showing posts with label Remyelination. Show all posts
Showing posts with label Remyelination. Show all posts

Saturday, April 11, 2015

What is "The Cure"?

If you had asked me what The Cure was in college, I’d say an English rock band that was fun to listen to because their music was SO DIFFERENT from the classical music of Bach, Beethoven, Brahms, Chopin, Czerny, Debussy, Mozart, Prokofiev, Strauss, Tchaikovsky, Kabalevsky, and more, I studied and performed every day while in music school.

If you had asked me what The Cure was just a few years ago, in reference to multiple sclerosis, I’d say a treatment that got rid of MS for good, transforming an incurable disease into a curable one through some amazing mode of action that worked for everybody stricken with this bizarre and relentless disease that frequently wreaks neurological havoc. Basically, I pictured no new attacks or damage, ever.

If you ask me what The Cure is today, I would first ask what YOU mean by cure — because we each have different ideas and opinions on these types of issues.

When I picture what the cure for MS might look like, I think of something that not just stops disease progression, but which reverses the damage that MS causes to the central nervous system. Complete eradication of the disease may be a successful cure. But look at diseases such as measles which was supposed eradicated from the US in 2000, it has come back due to lapses in vaccination practices. However, MS is quite different than the measles so that’s not a fair comparison.

Does remyelination equate “cure” in your book?
In thinking of my own experience with MS, my current disease-modifying treatment seems to have practically halted disease progression in recent years. Certainly I still experience many MS symptoms, especially the kind that get worse when I’m not feeling well, overheated, fatigued, or sick. I have damage that will likely never improve.

However, this overall improvement of my MS didn’t happen immediately; in fact, I used pulse steroids during the first year after switching medications because things just wouldn’t calm down. I even had some relapses about the same time I was due for a round of infusions but had been putting it off.

But once I got on a regular pre-emptive schedule with the infusions, things began to get better. I regained strength and function and haven’t had a major relapse in four years. My MRI scans are stable, even improved from two years ago. No new lesions in the brain or spine, and my cervical lesions have become smaller.

It’s not a cure, but definitely a huge success in my estimation. To be “cured” of MS, I would like to not experience any significant residual damage from previous attacks. I would like to experience complete remyelination. What my body has done on its own is great, but I’d like to see more.

So that’s what I would like to see as the cure of MS — no disease activity, no symptoms, no neurological damage, no signs of MS whatsoever.


Read this post in its entirety:
What is the MS Cure?

Monday, May 19, 2014

Human Stem Cells Help Mice Regain Mobility

Researchers at the University of California stumbled upon an unexpected outcome while studying the common problem of stem cell rejection following transplantation.  Scientists injected human neural precursor cells (hNPCs) derived from human embryonic stem cells (hESCs) into the spinal cords of mice infected with the neurotropic JHM strain of mouse hepatitis virus (JMHV) http://www.ncbi.nlm.nih.gov/pubmed/11935460 .  Persistent infection with this particular virus causes an MS-like condition in mice characterized by demyelination, neuroinflammation, and hind-limb paralysis. 

As expected, the stem cells injected into the JHMV-infected mice were completely rejected by the immune system within 8 days.  However, unexpectedly, the hNPC-transplanted mice experienced improved motor skills and a reduction in neuroinflammation and demyelination about two weeks after the injections.  Results of a follow-up study cofunded by the National MS Society and the California Institute for Regenerative Medicine are published in the journal Stem Cell Reports in the article, “Human Neural Precursor Cells Promote Neurologic Recovery in a Viral Model of Multiple Sclerosis.”

Read this post in its entirety:

Mice with MS-like Disease Unexpectedly Walk After Stem Cell Transplantation

Sunday, May 18, 2014

Modeling MS in Mice to Study Remyelination

To investigate potential causes and treatments for demyelinating diseases such as MS, researchers use various methods to cause a condition or symptoms similar to MS in laboratory animals.  Mice do not naturally develop MS, but mice are especially suited to studying MS-like disease because of their similarity to humans in anatomy, physiology, and genetics.  Researchers are able to create various genetic modifications in mice to mimic human disease.  Mice are small, inexpensive, and can reproduce quickly.

There are three major types of animal models used to study demyelinating disease: 1) genetic models, where genes important for CNS myelination, myelin maintenance or glial function have been altered; 2) immune-mediated models of induced pathogenesis towards myelin; and 3) toxin-mediated models using toxic substances that preferentially affect myelin (Pohl, 2011).
- See more at: http://www.healthcentral.com/multiple-sclerosis/c/19065/169331/sclerosis-disease#sthash.WodvrOeA.dpuf
To investigate potential causes and treatments for demyelinating diseases such as MS, researchers use various methods to cause a condition or symptoms similar to MS in laboratory animals.  Mice do not naturally develop MS, but mice are especially suited to studying MS-like disease because of their similarity to humans in anatomy, physiology, and genetics.  Researchers are able to create various genetic modifications in mice to mimic human disease.  Mice are small, inexpensive, and can reproduce quickly. 

There are three major types of animal models used to study demyelinating disease: 1) genetic models, where genes important for CNS myelination, myelin maintenance or glial function have been altered; 2) immune-mediated models of induced pathogenesis towards myelin; and 3) toxin-mediated models using toxic substances that preferentially affect myelin (Pohl, 2011).

Read this post in its entirety:

Multiple Sclerosis Research: Studying MS-like Disease in Mice